Related Business Topics
Latest Headlines
Reuters - Nov. 24, 2009, 2:02 PM
3:56pm EST storyKeywords RTR_ArticleTitle 'BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent RTR_ArticleBlurb 'http://www.businesswire.com/news/home/20091124006076/en Records Increase of $9 Million in Shareholders' Equity ...
Forbes.com - Nov. 24, 2009, 1:29 PM
BusinessWire - -- Receives First Installment of California-Sponsored Grant Funds -- -- Forms Two New Subsidiaries: BioTime Asia and OncoCyte Corporation -- -- Common Shares and Warrants Listed on the NYSE Amex -- BioTime, Inc. (NYSE Amex:BTIM) reported ...
Forbes.com - Nov. 16, 2009, 4:36 PM
NEW YORK For the 2010 edition, the Investors' Choice awards are for the categories of Best IR Program and Best IR Officer. This is the only award defined by direct vote. The Investors' Choice ranking complements the IR Global Ranking's technical ...
Forbes.com - Nov. 13, 2009, 4:29 PM
GENZYME-FDA/ (UPDATE 4):UPDATE 4- * Particles found in less than 1 pct of affected drugs * Potential for adverse reactions but none reported * Genzyme ( GENZ - news - people ) shares drop more than 7 percent (Updates with comments from company, analysts, ...
Forbes.com - Nov. 13, 2009, 4:24 PM
WASHINGTON/BOSTON, Nov 13 (Reuters) - Stainless steel fragments, non-latex rubber and fiber-like material have been found in some drugs made by Genzyme Corp, dealing another blow to a company already struggling with manufacturing problems. The U.S. Food ...
Reuters - Nov. 13, 2009, 4:16 PM
* Particles found in less than 1 pct of affected drugs * Potential for adverse reactions but none reported * Genzyme shares drop more than 7 percent (Updates with comments from company, analysts, FDA) WASHINGTON/BOSTON, Nov 13 (Reuters) - Stainless steel ...
Forbes.com - Nov. 12, 2009, 10:37 AM
CHAPEL HILL, N.C. The report, Using Marketing Benchmarks to Assess Productivity and Service Levels at Medical Device Companies, contains benchmark metrics that allow marketing executives to assess marketing staffing and activities against growth and ...
Forbes.com - Nov. 10, 2009, 9:13 AM
Nov 10 (Reuters) - Hospira Inc: * Says to redeem all $375 million of floating rate notes due March 30, 2010 on December 17, 2009 - SEC filing ((Bangalore ...
Reuters - Nov. 9, 2009, 4:26 PM
Akorn, Inc. is engaged in manufacturing and marketing diagnostic and therapeutic pharmaceuticals in specialty areas, such as ophthalmology, rheumatology, anesthesia and antidotes, among others. In addition, the Company markets and distributes vaccines ...
New York Times - Nov. 6, 2009, 3:44 PM
The following recall has been announced: Hospira Inc., a global specialty pharmaceutical and medication delivery company, is voluntarily recalling certain anesthetics because of possible contamination. The recalled items are 85 lots of Liposyn II 10 ...
